Episode Details

Back to Episodes
Scientists Found a New Way to Open the Eye's Natural Drainage System — Could It Lead to Better Glaucoma Drops?

Scientists Found a New Way to Open the Eye's Natural Drainage System — Could It Lead to Better Glaucoma Drops?

Published 5 days, 17 hours ago
Description

This audio article is from VisualFieldTest.com.

Read the full article here: https://visualfieldtest.com/en/scientists-found-a-new-way-to-open-the-eye-s-natural-drainage-system-could-it-lead-to-better-glaucoma-drops

Test your visual field online: https://visualfieldtest.com

Support the show so new episodes keep coming: https://www.buzzsprout.com/2563091/support

Excerpt:

Scientists Found a New Way to Open the Eye’s Natural Drainage System — Could It Lead to Better Glaucoma Drops? A study published on November 5, 2026 points to a possible new way to improve the eye’s natural fluid drainage: change the mechanical behavior of the cells lining Schlemm’s canal, a circular drainage channel near the front of the eye. In laboratory experiments, the cancer drug paclitaxel altered these cells’ stiffness and pore formation. In isolated mouse eyes, it increased measured fluid outflow facility by 44.3%. That is an intriguing result—but it is not evidence that paclitaxel is a glaucoma treatment, and the experiment did not show a 44.3% fall in eye pressure. The study used cultured human cells and short-term experiments in enucleated mouse eyes, not people receiving eye drops. It also leaves open questions about which drainage tissues produced the effect, whether the proposed signaling pathway explains it, and whether a safer drug can reproduce it. The most careful answer to the central question is: possibly. Restoring a healthier mechanical response in the drainage pathway could become a useful treatment strategy, but the drug, delivery method, and clinical benefit are not yet established. The November 2026 study and its PubMed record () How the eye’s natural drainage system works The eye continually makes a clear fluid called aqueous humor. It flows from behind the iris, through the pupil, and into the front chamber of the eye. Most then leaves through the conventional outflow pathway: It passes through the trabecular meshwork, a porous tissue at the eye’s drainage angle. It crosses a thin layer of cells lining the inner wall of Schlemm’s canal. It enters the canal, then passes into collector channels and veins before joining the circulation. A smaller, separate amount leaves through the uveoscleral pathway, through tissues near the ciliary muscle. The conventional pathway is pressure-dependent: generally, fluid leaves faster when the pressure inside the eye is higher than the pressure in the veins receiving it. The conventional route and aqueous humor circulation are summarized by the National Center for Biotechnology Information () How fluid crosses Schlemm’s canal’s inner wall The inner wall is not simply a passive sieve. Its endothelial cells respond to pressure and stretch. As aqueous humor pushes against them, the cells can bulge toward the canal, forming temporary, fluid-filled outpouchings called giant vacuoles. A pore can form through a stretched cell, allowing fluid to pass into the canal; this is a transcellular pore. Fluid can also pass between neighboring cells through paracellular, or border, pores. A review of Schlemm’s canal cell physiology and a recent review of canal development and function describe both routes. () Pore formation is relevant to glaucoma, but it is not a settled, simple measurement of drainage. Studies of human donor eyes have reported fewer pores in glaucoma, while also showing that postmortem time and tissue fixation affect the apparent pore count. Some researchers have cautioned that at least some observed pores could be artifacts of tissue preparation. A human-eye study reported lower pore density in glaucoma; another study documented the influence of fixation conditions. () What the

Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us